This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Kurume University, Saga University. Active years: 2013-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2013-2016
Title: Hisamichi Aizawa: Innovator in Medical Diagnostics
Introduction
Hisamichi Aizawa is a notable inventor based in Kurume, Japan. He has made significant contributions to the field of medical diagnostics, particularly in the detection of idiopathic interstitial pneumonia. With a total of 2 patents, Aizawa's work has the potential to impact patient care and treatment options.
Latest Patents
Aizawa's latest patents include a method for screening for a therapeutic agent for idiopathic interstitial pneumonia. This invention provides a method for detecting the condition by measuring the expression level of a periostin gene or the amount of a periostin protein in a biological sample. Additionally, he has developed a method for the detection of idiopathic interstitial pneumonia, which similarly involves measuring the expression level of a periostin gene or the amount of a periostin protein in a biological sample. These innovations offer valuable tools for diagnosing this challenging disease.
Career Highlights
Throughout his career, Aizawa has worked with esteemed institutions such as Saga University and Kurume University. His research and inventions have garnered attention in the medical community, showcasing his dedication to advancing healthcare through innovative solutions.
Collaborations
Some of Aizawa's notable coworkers include Kenji Izuhara and Shoichiro Ohta. Their collaborative efforts have contributed to the development of groundbreaking methods in medical diagnostics.
Conclusion
Hisamichi Aizawa's contributions to the field of medical diagnostics, particularly in the detection of idiopathic interstitial pneumonia, highlight his role as an influential inventor. His work continues to pave the way for advancements in patient care and treatment methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile